March 4, 2020 / 2:06 PM / a month ago

BRIEF-Generex Biotechnology Signs Contract With Epivax To Develop II-Key Peptide Vaccines To Address Coronavirus Pandemic

March 4 (Reuters) - Generex Biotechnology Corp:

* GENEREX BIOTECHNOLOGY CORP - SIGNS CONTRACT WITH EPIVAX TO DEVELOP II-KEY PEPTIDE VACCINES TO ADDRESS CORONAVIRUS PANDEMIC Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below